- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
TSX approves disposition of Jubilee zinc and lead project – Frontline Gold
Steel Guru.com reports that the TSX has approved the sale of Frontline Gold Corporation’s (CVE:FGC) 50% interest in the Jubilee Zinc Lead Project.
Steel Guru.com reports that the TSX has approved the sale of Frontline Gold Corporation’s (TSXV:FGC) 50% interest in the Jubilee Zinc Lead Project.
The story is quoted as saying:
The TSX Venture Exchange issued final approval to both Frontline and Merrex Gold Inc for the sale of Frontline’s 50% interest in the Jubilee Zinc Lead Project and related surface rights to Merrex for USD 500,000 to be paid by the issuance of 1,000,000 common shares of Merrex at a deemed issue price of USD 0.50 per share
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.